Biotech Values

[HattieTheWitch]

I would have preferred to see MNTA ink more lucrative terms in a deal for one or two FoB’s rather than a somewhat less lucrative deal that incorporates as many as six FoB’s and has a large number of moving parts.

And, unless I read things wrong, BAX has first right of refusal on products beyond 6 - meaning (to me) that the terms agreed to today, be they good, bad, or indifferent, will apply if BAX wants in on future "stuff".

That doesn't leave MNTA in a good negotiating position, once, as I presume will eventually happen, Mr. Market establishes a higher pps because MNTA will have better "proven" its value.

Your (and anyone else's) comments appreciated.